MENLO PARK, Calif.,
March 9, 2017 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty
pharmaceutical company developing products for the dermatology
market, today announced that its updated corporate presentation
will be webcast from the 29th Annual ROTH Conference in
Dana Point, Calif.
BioPharmX co-founder and President Anja
Krammer will provide an updated overview of the company at
the conference on Monday, March 13,
at 10 a.m. PST in Pink – Salon 5
conference room of the Ritz Carlton Hotel.
The live webcast will be available at
http://wsw.com/webcast/roth31/bpmx and a replay will be accessible
for 90 days following the presentation.
The annual ROTH Conference, hosted by ROTH Capital Partners
March 12 to 15, is one of the largest
gatherings of institutional investors, private equity investors,
VCs, company executives and service providers in the small- and
mid-cap space.
About BioPharmX® Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company that seeks to provide products through proprietary platform
technologies for prescription, over-the-counter and supplement
applications in dermatology and women's health. To learn more about
BioPharmX, visit www.BioPharmX.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-to-present-at-29th-annual-roth-conference-300420872.html
SOURCE BioPharmX Corporation